Validations: Hold-Time Studies (Bulk, Intermediate & Cleaning)
Adding New Products to Existing Hold Claims Adding New Products to Existing Hold Claims This article provides detailed guidance for adding new products to existing hold claims in the pharmaceutical industry. The main focus is on understanding equipment hold time, especially for bulk and intermediate holds, as well as establishing robust microbial limits, conducting endotoxin limit tests, and utilizing bioburden…
Seasonal/Environmental Changes: Revisiting Hold Claims Seasonal/Environmental Changes: Revisiting Hold Claims The pharmaceutical industry operates under stringent regulations, ensuring that products maintain quality and safety throughout their lifecycle. One critical aspect of this process is understanding hold times for both bulk materials and equipment. This article serves as a comprehensive tutorial on revisiting hold claims, addressing the implications of seasonal and…
Deviation Learnings as Triggers for Re-Work Deviation Learnings as Triggers for Re-Work Introduction to Equipment Hold Time Studies In the pharmaceutical industry, maintaining compliance with regulatory expectations around hold times is crucial for ensuring product quality and safety. Equipment hold time studies assess the validity of operational procedures relating to the storage of drugs or intermediate products, particularly concerning bulk…
Re-Verification Protocols: Smart, Fast, Defensible Re-Verification Protocols: Smart, Fast, Defensible Understanding Hold Time in Pharmaceutical Manufacturing In pharmaceutical manufacturing, understanding hold time for equipment, bulk products, and intermediates is essential for ensuring product quality and compliance with regulatory standards set forth by the FDA, EMA, MHRA, and PIC/S. Hold time refers to the maximum duration an item may remain in…
Bridging Data Across Sites: Bias and Parity Understanding Equipment Hold Time: Importance and Regulatory Context Equipment hold time is a critical consideration in pharmaceutical manufacturing, ensuring product integrity and compliance. Hold times refer to the period during which materials (both bulk drug substances and intermediates) can safely remain in production equipment without compromising quality. The regulatory landscape emphasizes the need…
Documentation Packages for Extension Requests Introduction to Extension Requests in Hold-Time Studies The pharmaceutical industry is governed by strict guidelines to ensure the quality and safety of medicinal products. Extensions related to hold-time studies—specifically for bulk and intermediate products—are particularly relevant in this context. Regulatory bodies such as the US FDA, EMA, and MHRA emphasize the importance of well-documented procedures…
Material/Component Changes: Impact on Hold-Time Material/Component Changes: Impact on Hold-Time In pharmaceutical manufacturing, maintaining the integrity and quality of products during hold times is crucial. This tutorial serves as a step-by-step guide aimed at providing pharmaceutical professionals with a comprehensive understanding of how material and component changes can impact hold-time studies, specifically concerning bulk, intermediate, and cleaning holds. This guide…
Cleaning Agent or CIP Change: Hold-Time Consequences Understanding the implications of cleaning agent or Clean-In-Place (CIP) changes related to hold-time studies is paramount in pharmaceutical operations. This detailed tutorial examines the necessary steps for valid and compliant hold-time assessments focusing on equipment, bulk, and intermediate holds, while adhering to regulatory expectations such as 21 CFR Part 211 and Annex 15….
Equipment Modifications: Dead-Legs, Ports, and Valves Equipment Modifications: Dead-Legs, Ports, and Valves This guide provides a comprehensive step-by-step approach for pharmaceutical professionals focused on the validation of equipment modifications. The aim is to maintain compliance with regulatory requirements while understanding equipment hold times, microbial limits, and the associated sampling plans necessary for ensuring product quality and safety. This tutorial highlights…
Supplier Changes: Letters of Guarantee and Bridging Supplier Changes: Letters of Guarantee and Bridging In the pharmaceutical industry, maintaining compliance with regulatory expectations is paramount to ensuring product quality and safety. One of the critical factors in maintaining compliance involves understanding the nuances of equipment hold time, especially when changes occur within the supplier environment. This comprehensive guide aims to…